ROCKWELL MEDICAL, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $69.3M | $101.5M | $83.6M | $72.8M | $61.9M |
| Cost of revenue | $57.6M | $84.0M | $74.9M | $68.7M | $64.4M |
| Gross profit | $11.7M | $17.5M | $8.7M | $4.1M | -$2.4M |
| Research and development | $0 | $19,000 | $1.1M | $3.1M | $6.8M |
| Operating income | -$4.7M | $608,000 | -$6.7M | -$16.8M | -$30.3M |
| Interest expense | $1.1M | $1.3M | $2.3M | $1.9M | $2.4M |
| Pretax income | -$5.3M | -$480,000 | -$8.4M | — | — |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$5.3M | -$480,000 | -$8.4M | -$18.7M | -$32.7M |
| Balance Sheet | |||||
| Cash and equivalents | $10.7M | $15.7M | $9.0M | $10.1M | $13.3M |
| Current assets | $38.2M | $37.0M | $28.8M | $35.3M | $35.3M |
| Total assets | $57.1M | $59.2M | $52.2M | $46.6M | $48.6M |
| Current liabilities | $9.6M | $14.1M | $16.6M | $17.7M | $21.0M |
| Total liabilities | $20.2M | $26.6M | $30.9M | $32.5M | $46.0M |
| Stockholders' equity | $37.0M | $32.6M | $21.3M | $14.1M | $2.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$659,000 | $4.2M | -$9.4M | -$16.9M | -$33.5M |
| Depreciation and amortization | $2.2M | $2.2M | $1.4M | $576,000 | $668,000 |
| Stock-based compensation | $1.8M | $1.3M | $932,000 | $315,000 | $943,000 |
| Capital expenditure | $542,000 | $1.0M | $284,000 | — | — |
| Free cash flow | -$1.2M | $3.2M | -$9.7M | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 39.5M · Free float 76.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.